LONDON (Reuters) - Shares in London-listed drugmaker Shire Plc jumped nearly 6 percent on Tuesday after Reuters reported that Botox-maker Allergan Inc was preparing a new takeover approach. Allergan ...
LONDON (Reuters) - Shire Plc (SHP.L) shares gained more than 3 percent on Monday following news U.S. regulators had approved NPS Pharmaceuticals Inc's (NPSP.O) drug Natpara, validating Shire's ...
Shire Plc American Depositary Receipts jumped almost 7% in premarket trade Thursday, after the company reported positive results from a late-stage trial of a treatment for Hereditary Angioedema (HAE), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results